Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001513965 | SCV001721681 | benign | not provided | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001513965 | SCV001897132 | benign | not provided | 2021-05-04 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 16014697) |
Unidad de Genómica Garrahan, |
RCV003488339 | SCV004232971 | benign | not specified | 2024-01-24 | criteria provided, single submitter | clinical testing | This variant is classified as Benign based on local population frequency. This variant was detected in 87% of patients studied by a panel of primary immunodeficiencies. Number of patients: 83. Only high quality variants are reported. |
Breakthrough Genomics, |
RCV001513965 | SCV005231518 | benign | not provided | criteria provided, single submitter | not provided | ||
OMIM | RCV000015022 | SCV000035278 | uncertain significance | OAS1 polymorphism | 2006-02-01 | no assertion criteria provided | literature only | |
Prevention |
RCV003974825 | SCV004798875 | benign | OAS1-related disorder | 2019-05-17 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |